Q4 2020

Filed Sep 23, 2020 · 10-K · 85 days after period end · 0001193125-20-252381

Q4 2020 · 10-K

derived · Computed from the longer spans the company filed.

Revenue—

Net Income

-$2.94M

derivedno prior Q4 2019 on file

EPS, diluted—Not derived. Share counts vary by quarter.

Operating Incomederived-$2,893,000—

Same quarter

no prior Q4 2019 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Jun 30, 2020 · filed Sep 23, 2020 · 85 d after period end

Benitec Biopharma Inc. · CIK 1808898 · Engraved from SEC EDGAR